PB1926: REAL-WORLD ERYTHROPOIESIS-STIMULATING AGENT (ESA) TREATMENT PATTERNS AND OUTCOMES AMONG US PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES (LR-MDS)

Detalles Bibliográficos
Autores principales: Mukherjee, S., Zimmerman Savill, K., Gajra, A., Kish, J., Brown-Bickerstaff, C., Gentile, D., Falkenstein, A., Miller, T., Laney, J., McBride, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Publication Only
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431560/
http://dx.doi.org/10.1097/01.HS9.0000850556.55678.1f

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431560/
http://dx.doi.org/10.1097/01.HS9.0000850556.55678.1f

Ejemplares similares